UK markets open in 1 hour 32 minutes
NIKKEI 225
39,168.27 +130.11 (+0.33%) HANG SENG
18,067.46 -299.49 (-1.63%) CRUDE OIL
77.73 -0.01 (-0.01%) GOLD FUTURES
2,318.90 -8.10 (-0.35%) DOW
38,868.04 +69.05 (+0.18%) Bitcoin GBP
53,290.94 -1,334.66 (-2.44%)
Novavax, Inc. (NVAX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 18.17 |
| Open | 17.81 |
| Bid | 15.99 x 2800 |
| Ask | 16.13 x 1300 |
| Day's range | 15.40 - 17.86 |
| 52-week range | 3.53 - 23.86 |
| Volume | |
| Avg. volume | 14,361,098 |
| Market cap | 2.358B |
| Beta (5Y monthly) | 1.95 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -3.05 |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 21.60 |
ZacksModerna (MRNA) Submits Updated COVID-19 Jab to FDA for Review
Moderna (MRNA) completes regulatory filing of its Spikevax 2024-2025 formula, targeting the COVID-19 variant JN.1 to the FDA for the upcoming vaccination season.
ZacksInvestors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
Zacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Simply Wall St.Novavax, Inc. (NASDAQ:NVAX) has caught the attention of institutional investors who hold a sizeable 49% stake
Key Insights Institutions' substantial holdings in Novavax implies that they have significant influence over the...
© 2024 Yahoo. All rights reserved.